{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:15:02Z","timestamp":1760188502584},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1992,4,1]],"date-time":"1992-04-01T00:00:00Z","timestamp":702086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[1992,4]]},"DOI":"10.1007\/bf01696219","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T06:58:15Z","timestamp":1116140295000},"page":"173-180","source":"Crossref","is-referenced-by-count":39,"title":["A randomized phase-I\/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia"],"prefix":"10.1007","volume":"64","author":[{"name":"EORTC Leukemia Cooperative Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Willemze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"van der Lely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Zwierzina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Suciu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Solbu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Gerhartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Labar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Visani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Stryckmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. L.","family":"Haak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. M.","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Baumelou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Mandelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Jaksic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Louwagie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Thyss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Hayat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de Cataldo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. C.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zittoun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01696219_CR1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1182\/blood.V72.2.705.705","volume":"72","author":"JH Antin","year":"1988","unstructured":"Antin JH, Smith BR, Holmes W, Rosenthal DS (1988) Phase I\/II study of recombinant human granulocyte-macrophage colony-stimulating factor in aplastic anemia and myelodysplastic syndrome. Blood 72: 705\u2013713","journal-title":"Blood"},{"key":"BF01696219_CR2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel DT, Flandrin G, Galton DAG, Gralnick HR, Sultan C (1982) The French-American-British (FAB) Cooperative Group. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51: 181\u2013199","journal-title":"Br J Haematol"},{"key":"BF01696219_CR3","first-page":"381","volume-title":"Cancer clinical trials: methods and practice","author":"N Breslow","year":"1984","unstructured":"Breslow N (1984) Comparison of survival curves. In: Buyse M, Staquet M, Sylvester R (eds) Cancer clinical trials: methods and practice. Oxford University Press, Oxford, pp 381\u2013406"},{"key":"BF01696219_CR4","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/1097-0142(19900901)66:5<831::AID-CNCR2820660503>3.0.CO;2-E","volume":"66","author":"T Witte De","year":"1990","unstructured":"De Witte T, Muus P, De Pauw B, Haanen C (1990) Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 66: 831\u2013837","journal-title":"Cancer"},{"key":"BF01696219_CR5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2141.1991.tb08573.x","volume":"77","author":"EH Estey","year":"1991","unstructured":"Estey EH, Kurzrock P, Talpaz M, McCredie KB, O'Brien S, Kantarjian HM, Keating MJ, Deisseroth AB, Gutterman JU (1991) Effects of low doses of recombinant human granulocy-temacrophage colony-stimulating factor (GM-CSF) in patients with myelodysplastic syndromes. Br J Haematol 77: 291\u2013295","journal-title":"Br J Haematol"},{"key":"BF01696219_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V73.1.31.31","volume":"73","author":"A Ganser","year":"1989","unstructured":"Ganser A, V\u00f6lkers B, Greher J, Ottmann OG, Walter F, Becher R, Bergmann L, Schulz G, Hoelzer D (1989) Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes \u2014 a phase I\/II trial. Blood 73: 31\u201337","journal-title":"Blood"},{"key":"BF01696219_CR7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2141.1987.tb06138.x","volume":"65","author":"H Kerkhofs","year":"1987","unstructured":"Kerkhofs H, Hermans J, Haak HL, Leeksma CH (1987) Utility of the FAB classification for myelodysplastic syndromes: investigation of prognostic factors in 237 cases. Br Haematol 65: 73\u201381","journal-title":"Br Haematol"},{"key":"BF01696219_CR8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0002-9343(89)90265-9","volume":"86","author":"Y Kobayashi","year":"1989","unstructured":"Kobayashi Y, Okabe T, Ozawa K, Chiba S, Hino M, Miyazono K, Urabe A, Takaku F (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report. Am J Med 86: 178\u2013182","journal-title":"Am J Med"},{"key":"BF01696219_CR9","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0308-2261(18)30013-4","volume":"15","author":"HP Koeffler","year":"1986","unstructured":"Koeffler HP (1986) Preleukaemia. Clin Haematol 15: 829\u2013849","journal-title":"Clin Haematol"},{"key":"BF01696219_CR10","first-page":"276","volume-title":"Cancer clinical trials: methods and practice","author":"SW Lagakos","year":"1984","unstructured":"Lagakos SW, Pocock SJ (1984) Randomization and stratification in cancer clinical trials: an international survey. In: Buyse M, Staquet M, Sylvester R (eds): Cancer clinical trials: methods and practice. Oxford University Press, Oxford, pp 276\u2013286"},{"key":"BF01696219_CR11","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2141.1985.tb07329.x","volume":"59","author":"GJ Mufti","year":"1985","unstructured":"Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D (1985) Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 59: 425\u2013433","journal-title":"Br J Haematol"},{"key":"BF01696219_CR12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.7326\/0003-4819-110-12-976","volume":"110","author":"RS Negrin","year":"1989","unstructured":"Negrin RS, Haeuber DH, Nagler A, Olds LC, Donlon T, Souza LM, Greenberg PL (1989) Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor. Ann Intern Med 110: 976\u2013984","journal-title":"Ann Intern Med"},{"key":"BF01696219_CR13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1182\/blood.V76.1.36.36","volume":"76","author":"RS Negrin","year":"1990","unstructured":"Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76: 36\u201343","journal-title":"Blood"},{"key":"BF01696219_CR14","first-page":"361","volume-title":"Cancer clinical trials: methods and practice","author":"J Peto","year":"1984","unstructured":"Peto J (1984) The calculation and interpretation of survival curves. In: Buyse M, Staquet M, Sylvester R (eds) Cancer clinical trials: methods and practice. Oxford University Press, Oxford, pp 361\u2013380"},{"issue":"10","key":"BF01696219_CR15","first-page":"318","volume":"76","author":"MW Schuster","year":"1990","unstructured":"Schuster MW, Larson RA, Thompson JA, Coiffier B, Bennett JM, Israel RJ (1990) Granulocyte-macrophage colony-stimulating factor (GM-CSF) for myelodysplastic syndrome (MDS): results of a multi-center randomized controlled trial. Blood 76: 10: 318","journal-title":"Blood"},{"key":"BF01696219_CR16","volume-title":"Non-parametric statistics for behavioral sciences","author":"S Siegel","year":"1956","unstructured":"Siegel S (1956) Non-parametric statistics for behavioral sciences. McGraw-Hill, New York"},{"key":"BF01696219_CR17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0165-4608(90)90193-E","volume":"44","author":"S Suciu","year":"1990","unstructured":"Suciu S, Kuse R, Weh HJ, Hossfeld DK (1990) Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de novo myelodysplastic syndrome. Cancer Genet Cytogenet 44: 15\u201326","journal-title":"Cancer Genet Cytogenet"},{"key":"BF01696219_CR18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1200\/JCO.1989.7.5.629","volume":"7","author":"JA Thompson","year":"1989","unstructured":"Thompson JA, Lee DJ, Kidd P, Rubin E, Kaufmann J, Bonnem EM, Fefer A (1989) Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics and hematological effects. J Clin Oncol 7: 629\u2013637","journal-title":"J Clin Oncol"},{"key":"BF01696219_CR19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1985.tb07381.x","volume":"60","author":"G Tricot","year":"1985","unstructured":"Tricot G, Vlietinck R, Boogaerts MA, Hendrickx B, De Wolf-Peeters C, Van den Berghe, Verwilghen RL (1985) Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis. Br J Haematol 60: 19\u201332","journal-title":"Br J Haematol"},{"key":"BF01696219_CR20","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1056\/NEJM198712173172501","volume":"317","author":"S Vadhan-Raj","year":"1987","unstructured":"Vadhan-Raj S, Keating M, LeMaistre A, Hittelman WN, McCredie K, Trujillo JM, Broxmeyer HE, Henney C, Gutterman JU (1987) Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. N Engl J Med 317: 1545\u20131551","journal-title":"N Engl J Med"},{"key":"BF01696219_CR21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1182\/blood.V70.2.404.404","volume":"70","author":"A Yuo","year":"1987","unstructured":"Yuo A, Kitagawa S, Okabe T, Urabe A, Komatsu Y, Itoh S, Takaku F (1987) Recombinant human granulocyte colonystimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia. Blood 70: 404\u2013411","journal-title":"Blood"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01696219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01696219\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01696219","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T00:26:02Z","timestamp":1625963162000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01696219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,4]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1992,4]]}},"alternative-id":["BF01696219"],"URL":"https:\/\/doi.org\/10.1007\/bf01696219","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[1992,4]]}}}